Tactile Medical, 3M, and Essity (BSN medical GmbH) dominated the North America Lymphedema Treatment Market in 2021

North America Lymphedema Treatment Market is expected to grow with a CAGR of 9.7% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-lymphedema-treatment-market

North America lymphedema treatment market is a highly consolidated market. The market has witnessed increased strategic developments owing to a favorable market scenario.

The major players dealing in the North America lymphedema treatment market are introducing a strong range of product portfolios. This helped companies to maximize sales with an enhanced product portfolio.

  • In December 2018, 3M announced an agreement to acquire the technology business of M*Modal, for a total enterprise value of USD 1.0 billion. M*Modal is acquired so they can spend more time with its patients and provide a higher quality of care. This helped the company to increase its revenue

Tactile Medical is the dominating player in the market. Some of the other major manufacturers for the North America lymphedema treatment market are BIOCOMPRESSION SYSTEMS, Lohmann & Rauscher GmbH & Co. KG, ThermoTek, Essity (BSN medical GmbH), Cardinal Health, Smith+Nephew, Avet Pharmaceuticals Inc., KOYA MEDICAL, SIGVARIS GROUP, AIROS Medical, Inc., Tactile Medical, medi GmbH & Co. KG, PAUL HARTMANN AG, Convatec Inc., 3M, JUZO, Mego Afek ltd, Huntleigh Healthcare Limited, HERANTIS PHARMA Plc, among others.

Tactile Medical

Tactile Medical was founded in 1957 and is headquartered in Minnesota, United States. It has public ownership. The company focuses on developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency. The company offers a range of product categories, including head and neck, upper body, lower body which are also the market-focused categories.

  • In September 2021, Tactile MEDICAL announced the enrollment of the first patient in a randomized, controlled clinical trial evaluating the effectiveness of Flexitouch plus for the treatment of head and neck lymphedema. This will increase the credibility of the company in the market

The company has a global presence in North America. The company has a subsidiary, Swelling Solutions, Inc. (U.S.).

Essity (BSN medical GmbH)

Essity (BSN medical GmbH) was founded in 1950 and is headquartered in Hamburg, Germany. It has private ownership. The company focuses on improving well-being through leading hygiene and health solutions. The company offers a range of product categories, including phlebology, lymphology, chronic venous disease, lymphedema, chronic venous insufficiency, thrombosis prophylaxis, and chronic edema, out of which lymphedema is the market-focused category. The company is taking strategic initiatives to increase its portfolio.

  • In August 2021, the company finalized its acquisition of 45.8% of the shares in Productos Familia S.A. Essity now owns 95.8% of Familia. The purchase price amounts to USD 1,540m for 100% of the company on a debt-free basis. The acquisition is expected to be accretive to Essity's earnings per share from 2021. This acquisition helped the company to grow its portfolio and helped to increase sales in upcoming years

The company has a global presence in Europe.

3M

3M was founded in 1902 and is headquartered in Minnesota, U.S. It has public ownership. The company's main focus is on advanced wound care and specialty surgical applications. The company's business segments include safety and industrial, transportation and electronics, health care, consumer, out of which health care is the market-focused segment. The company offers various product categories such as abrasive, sealant, filler, building material, cleaning supplies, coatings, insulation, lab supplies and testing, labels, lubricants, medical tapes, bandages, and wraps, out of which the market-focused categories are bandages and wraps. The company is taking strategic initiatives to increase its portfolio.

  • In March 2019, 3M announced the new business realignment of the company from five to four business segments. This new alignment enabled the company to serve its customers and markets better and to enhance the company profile

The company has a global presence in North America, Europe, the Middle East and Africa, Asia-Pacific, and South America. Some of the subsidiaries of the company include 3M Membrane Filtration (formerly Membrana) (Germany), 3M Food Safety (United Kingdom), 3M Purification Inc. (Connecticut), and 3M Personal Safety Division (Minnesota), among others.